✦ LIBER ✦

Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations

✍ Scribed by Caroline L. Alvares; Tino Schenk; Sanna Hulkki; Toon Min; Gowri Vijayaraghavan; Jenny Yeung; David Gonzalez; Chi W. E. So; Mel Greaves; Ian Titley; Kerol Bartolovic; Gareth Morgan

Book ID: 108677327
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 553 KB
Volume: 154
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08748.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gö6976 is a potent inhibitor of the JAK

Gö6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells

✍ Victoria L. Grandage; Tamara Everington; David C. Linch; Asim Khwaja 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

Acute myeloid leukaemia blast cells with

Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication

✍ Adam J. Mead; Rosemary E. Gale; Panagiotis D. Kottaridis; Satomi Matsuda; Asim K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Myeloablative chemotherapy followed by a

Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype

✍ Salvatore Palmieri; Felicetto Ferrara; Franco Leoni; Stefania Ciolli; Filiberto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract In this study, we analysed the prognostic relevance of foetal liver tyrosine kinase 3 (FLT3) mutations in 73 patients with acute myeloid leukaemia (AML) with normal karyotype, who survived induction and consolidation and received autologous stem cell transplantation (ASCT) after success